Russell Investments Group, Ltd. Sangamo Therapeutics, Inc Transaction History

Russell Investments Group, Ltd.

$84.2 Billion
Q3 2025

A detailed history of Russell Investments Group, Ltd. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 50,653 shares of SGMO stock, worth $22,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,653

Previous 33,148 52.81%

Holding current value

$22,287

Previous $17,000 94.12%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$0.44 - $0.7 $7,702 - $12,253	17,505 Added 52.81%	50,653 $33,000
Q2 2025 Aug 13, 2025	SELL	$0.43 - $0.81 $45 - $85	-105 Reduced 0.32%	33,148 $17,000
Q1 2025 May 13, 2025	BUY	$0.66 - $1.37 $4,579 - $9,506	6,939 Added 26.37%	33,253 $21,000
Q4 2024 Feb 13, 2025	SELL	$0.78 - $2.87 $11,303 - $41,592	-14,492 Reduced 35.51%	26,314 $26,000
Q3 2024 Nov 13, 2024	BUY	$0.32 - $1.1 $5,833 - $20,051	18,229 Added 80.74%	40,806 $35,000

Q2 2024 Aug 08, 2024	BUY	$0.36 - $0.65 $5,867 - $10,594	16,299 Added 259.62%	22,577 $8,000
Q1 2024 May 08, 2024	SELL	$0.42 - $1.38 $39,792 - $130,746	-94,744 Reduced 93.79%	6,278 $4,000
Q4 2023 Feb 05, 2024	SELL	$0.3 - $0.63 $383 - $805	-1,279 Reduced 1.25%	101,022 $54,000
Q3 2023 Nov 13, 2023	SELL	$0.58 - $1.47 $1,384 - $3,508	-2,387 Reduced 2.28%	102,301 $61,000
Q2 2023 Aug 10, 2023	SELL	$1.11 - $1.74 $101,251 - $158,719	-91,218 Reduced 46.56%	104,688 $136,000
Q1 2023 May 09, 2023	BUY	$1.66 - $3.67 $156,944 - $346,980	94,545 Added 93.28%	195,906 $344,000
Q3 2022 Nov 04, 2022	BUY	$4.27 - $6.39 $290,193 - $434,270	67,961 Added 203.48%	101,361 $496,000
Q2 2022 Jul 29, 2022	BUY	$3.28 - $6.21 $109,552 - $207,414	33,400 New	33,400 $138,000
Q2 2021 Aug 04, 2021	SELL	$10.17 - $12.64 $790,351 - $982,304	-77,714 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$10.88 - $17.05 $352,174 - $551,891	-32,369 Reduced 29.4%	77,714 $964,000
Q4 2020 Feb 08, 2021	SELL	$9.23 - $18.18 $62,653 - $123,405	-6,788 Reduced 5.81%	110,083 $1.72 Million
Q3 2020 Nov 09, 2020	BUY	$9.38 - $12.48 $79,730 - $106,080	8,500 Added 7.84%	116,871 $1.1 Million
Q2 2020 Aug 05, 2020	BUY	$6.21 - $11.83 $317,275 - $604,406	51,091 Added 89.2%	108,371 $971,000
Q1 2020 May 06, 2020	SELL	$5.05 - $8.85 $222,260 - $389,506	-44,012 Reduced 43.45%	57,280 $364,000
Q3 2019 Nov 01, 2019	BUY	$9.05 - $12.22 $16,588 - $22,399	1,833 Added 1.84%	101,292 $917,000
Q4 2018 Feb 11, 2019	SELL	$9.51 - $16.6 $61,196 - $106,821	-6,435 Reduced 6.08%	99,459 $1.14 Million
Q3 2018 Oct 26, 2018	BUY	$13.05 - $19.05 $913,291 - $1.33 Million	69,984 Added 194.89%	105,894 $1.8 Million
Q1 2018 May 11, 2018	SELL	$16.7 - $26.35 $50,851 - $80,235	-3,045 Reduced 7.82%	35,910 $682,000
Q4 2017 Feb 06, 2018	SELL	$11.6 - $17.35 $367,940 - $550,324	-31,719 Reduced 44.88%	38,955 $665,000
Q3 2017 Nov 07, 2017	BUY	$8.4 - $15.0 $593,661 - $1.06 Million	70,674	70,674 $1.06 Million

Others Institutions Holding SGMO

# of Institutions

124

Shares Held

62.5M

Call Options Held

953K

Put Options Held

1.11M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $68.9M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Sangamo Therapeutics, Inc Transaction History